S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Options trading has suddenly become more reliable. (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Top 5 AI Stocks to Buy for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Phathom Pharmaceuticals (PHAT) News Today

→ Your Money is Not Safe (From American Alternative) (Ad)
Free PHAT Stock Alerts
$8.97
-0.51 (-5.38%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Stock Rating Reaffirmed by Needham & Company LLC
marketbeat.com - April 19 at 3:27 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Alimera (ALIM)
markets.businessinsider.com - April 19 at 3:21 PM
markets.businessinsider.com logoBuy Rating Affirmed for Phathom Pharmaceuticals Amid Strong Uptake of V oquezna
markets.businessinsider.com - April 19 at 3:21 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.7%
marketbeat.com - April 19 at 1:59 PM
finance.yahoo.com logo12 Most Shorted Stocks in 2024
finance.yahoo.com - April 19 at 1:05 PM
marketbeat.com logoVanguard Group Inc. Has $19.94 Million Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)
marketbeat.com - April 15 at 4:14 AM
MarketBeat logoPhathom Pharmaceuticals (NASDAQ:PHAT) Trading Up 3%
americanbankingnews.com - April 14 at 3:14 AM
MarketBeat logoNeedham & Company LLC Reiterates "Buy" Rating for Phathom Pharmaceuticals (NASDAQ:PHAT)
americanbankingnews.com - April 13 at 6:48 AM
investing.com logoPhathom Pharmaceuticals CFO sells over $38k in company stock
investing.com - April 12 at 8:50 PM
MarketBeat logoPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT) CFO Molly Henderson Sells 3,435 Shares
americanbankingnews.com - April 12 at 5:50 AM
MarketBeat logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 6.2% Following Insider Selling
americanbankingnews.com - April 12 at 1:44 AM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 6.2% After Insider Selling
marketbeat.com - April 11 at 12:24 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Rating Reiterated by Needham & Company LLC
marketbeat.com - April 11 at 8:32 AM
insidertrades.com logoMolly Henderson Sells 3,435 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Stock
insidertrades.com - April 11 at 6:48 AM
markets.businessinsider.com logoBuy Rating Justified by Rhythm Pharmaceuticals’ Strong Market Entry and Promising Pipeline
markets.businessinsider.com - April 10 at 1:19 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)
markets.businessinsider.com - April 9 at 10:35 AM
msn.com logoPhathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
msn.com - April 7 at 8:26 AM
markets.businessinsider.com logoOptimistic Outlook for Phathom Pharmaceuticals’ Voquezna Despite Prescription Data Fluctuations
markets.businessinsider.com - April 6 at 9:29 AM
finance.yahoo.com logoARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
finance.yahoo.com - April 5 at 7:28 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 5.5%
marketbeat.com - April 4 at 3:08 PM
finance.yahoo.com logoPhathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 3 at 8:05 AM
globenewswire.com logoPhathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 3 at 8:00 AM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 8.1%
marketbeat.com - April 2 at 3:17 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)
markets.businessinsider.com - April 1 at 5:09 PM
stockhouse.com logoPhathom Pharmaceuticals Launches Direct-to-Consumer Campaign, "VOQUEZNA Can Kick Some Acid"
stockhouse.com - March 28 at 10:04 PM
investing.com logoPhathom Pharmaceuticals CEO sells shares worth over $153,000
investing.com - March 28 at 10:04 PM
insidertrades.com logoPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Insider Terrie Curran Sells 16,851 Shares
insidertrades.com - March 27 at 5:26 AM
marketbeat.com logoTerrie Curran Sells 16,851 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Stock
marketbeat.com - March 26 at 6:42 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 5.6%
marketbeat.com - March 26 at 4:21 PM
finance.yahoo.com logoPhathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
finance.yahoo.com - March 26 at 9:36 AM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4.5%
marketbeat.com - March 25 at 5:33 PM
finance.yahoo.com logoSIGA Names Larry Miller General Counsel
finance.yahoo.com - March 25 at 7:39 AM
markets.businessinsider.com logoPositive Prescription Trends and Resilience Prompt Buy Rating for Phathom Pharmaceuticals
markets.businessinsider.com - March 23 at 4:14 AM
marketbeat.com logoPhathom Pharmaceuticals' (PHAT) "Buy" Rating Reaffirmed at Needham & Company LLC
marketbeat.com - March 22 at 2:58 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 6%
marketbeat.com - March 19 at 4:48 PM
marketbeat.com logoPhathom Pharmaceuticals' (PHAT) Buy Rating Reiterated at Needham & Company LLC
marketbeat.com - March 18 at 6:33 PM
seekingalpha.com logoPhathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
seekingalpha.com - March 18 at 6:59 AM
finance.yahoo.com logoPHAT Apr 2024 10.000 call
finance.yahoo.com - March 16 at 7:48 PM
seekingalpha.com logoPhathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 2:29 PM
markets.businessinsider.com logoMaintaining Neutral on Phathom Pharmaceuticals Amid Voquezna Launch Uncertainties
markets.businessinsider.com - March 9 at 8:29 AM
finance.yahoo.com logoPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 8 at 5:59 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)
markets.businessinsider.com - March 8 at 12:58 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Announces Quarterly Earnings Results, Beats Expectations By $0.12 EPS
marketbeat.com - March 8 at 10:32 AM
finance.yahoo.com logoQ4 2023 Phathom Pharmaceuticals Inc Earnings Call
finance.yahoo.com - March 8 at 7:57 AM
markets.businessinsider.com logoBuy Rating on Phathom Pharmaceuticals Amid Strong Voquezna Launch Demand
markets.businessinsider.com - March 7 at 5:56 PM
finance.yahoo.com logoPhathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ...
finance.yahoo.com - March 7 at 5:56 PM
investorplace.com logoPHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
investorplace.com - March 7 at 3:02 PM
marketbeat.com logoPhathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Up to $9.73
marketbeat.com - March 7 at 1:20 PM
globenewswire.com logoPhathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
globenewswire.com - March 7 at 8:00 AM
benzinga.com logoPreview: Phathom Pharmaceuticals's Earnings
benzinga.com - March 6 at 4:46 PM
Get Phathom Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAT and its competitors with MarketBeat's FREE daily newsletter.

Your Money is Not Safe (Ad)

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

PHAT Media Mentions By Week

PHAT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHAT
News Sentiment
▼
0.50

0.52
▲
Average
Medical
News Sentiment

PHAT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHAT Articles
This Week
▼
10

3
▲
PHAT Articles
Average Week

Get Phathom Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PHAT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends